[{"id":"17719ddc-bb4f-436a-93d2-9229a493717f","acronym":"","url":"https://clinicaltrials.gov/study/NCT01334060","created_at":"2021-02-01T11:52:26.190Z","updated_at":"2024-07-02T16:37:07.124Z","phase":"Phase 2","brief_title":"WT1 Immunity Via DNA Fusion Gene Vaccination in Haematological Malignancies by Intramuscular Injection Followed by Intramuscular Electroporation","source_id_and_acronym":"NCT01334060","lead_sponsor":"University Hospital Southampton NHS Foundation Trust","biomarkers":" ABL1 • BCR • WT1","pipe":" | ","alterations":" HLA-A*02:01","tags":["ABL1 • BCR • WT1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HLA-A*02:01"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e p.DOM-WT1-126 DNA vaccine"],"overall_status":"Completed","enrollment":" Enrollment 23","initiation":"Initiation: 02/01/2011","start_date":" 02/01/2011","primary_txt":" Primary completion: 02/01/2013","primary_completion_date":" 02/01/2013","study_txt":" Completion: 02/26/2013","study_completion_date":" 02/26/2013","last_update_posted":"2018-09-07"}]